Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Mann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Postgraduate Medicine|May 21, 1999
Are routine office procedures still worth your while?W S Mann
The Journal of Physiology|May 1, 1970
Enzymic and physiological studies on normal and disused developing fast and slow cat musclesW S Mann, B Salafsky
The Journal of Physiology|October 1, 1970
Development of the differential response to succinylcholine in the fast and slow-twitch skeletal muscle of the kittenW S Mann, B Salafsky
Medical Education|May 1, 1986
Computerizing clinical patient problems: an evolving tool for medical educationG C Pickell, D Medal, W S Mann, et al.
Federation Proceedings|April 1, 1984
Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S))P S Wolf, W S Mann, J T Suh, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist propertiesP S Wolf, T P Pruss, M J Rand, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dogW S Mann, E F Sales, R G Van Inwegen, et al.
Journal of Medicinal Chemistry|March 1, 1985
Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acidsP R Menard, J T Suh, H Jones, et al.
British Journal of Clinical Practice. Supplement|June 1, 1985
Celiprolol--pharmacological profile of an unconventional beta-blockerP S Wolf, R D Smith, A Khandwala, et al.
Journal of Medicinal Chemistry|January 1, 1985
Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivativesJ T Suh, J W Skiles, B E Williams, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Postgraduate Medicine|May 21, 1999
Are routine office procedures still worth your while?W S Mann
The Journal of Physiology|May 1, 1970
Enzymic and physiological studies on normal and disused developing fast and slow cat musclesW S Mann, B Salafsky
The Journal of Physiology|October 1, 1970
Development of the differential response to succinylcholine in the fast and slow-twitch skeletal muscle of the kittenW S Mann, B Salafsky
Medical Education|May 1, 1986
Computerizing clinical patient problems: an evolving tool for medical educationG C Pickell, D Medal, W S Mann, et al.
Federation Proceedings|April 1, 1984
Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S))P S Wolf, W S Mann, J T Suh, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist propertiesP S Wolf, T P Pruss, M J Rand, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1986
Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dogW S Mann, E F Sales, R G Van Inwegen, et al.
Journal of Medicinal Chemistry|March 1, 1985
Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acidsP R Menard, J T Suh, H Jones, et al.
British Journal of Clinical Practice. Supplement|June 1, 1985
Celiprolol--pharmacological profile of an unconventional beta-blockerP S Wolf, R D Smith, A Khandwala, et al.
Journal of Medicinal Chemistry|January 1, 1985
Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivativesJ T Suh, J W Skiles, B E Williams, et al.
Pageof 2